top of page
New Depression Treatment: FDA Approves J&J's Ketamine-Derived Nasal Spray, Improves Symptoms In 24 Hours
The U.S. FDA has approved Johnson & Johnson’s ketamine-based nasal spray for adults with major depressive disorder.
0
bottom of page
top of page
bottom of page